ReviewHepatology communications2026

Molecular biomarkers for diagnosis, prognosis, precision therapy, and immunotherapy in cholangiocarcinoma, cHCC-CCA, and HCC.

Jingguo Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.